It’s a virtual world: Curebase, AppliedVR joins home-based virtual reality clinical trials

Virtual reality, know virtual clinical trials.

AppliedVR will test its digital reality-based digital therapy through five studies using Curebase’s decentralized clinical trial software, the companies said Thursday.

The life sciences industry has been immersed in decentralized or virtual trials since the onset of the COVID-19 pandemic, and now AppliedVR wants to further test its 3D immersive headphones and glasses at patients ’homes.

RELATED: AppliedVR removes key regulatory barriers to using virtual reality to treat chronic pain

The Los Angeles medical technology company earned the FDA’s innovative designation for the use of its platform in chronic low back pain and treatment-resistant fibromyalgia. AppliedVR works with more than 240 hospitals to provide VR therapy for acute pain after surgery or during hospitalization.

The two startups tie their arms after each of them lifted Rounds of the Serie A earlier this year. AppliedVR grossed $ 29 million in March and Curebase raised $ 15 million in May.

Curebase will help AppliedVR test the platform across the entire pipeline of the digital therapy company, which also includes trials in earlier stages as a substitute for opioid prescriptions, treatment of generalized anxiety and other undisclosed indications, say Tom Lemberg, CEO of Curebase, in an interview with Fierce Biotech.

RELATED: Curebase Gets $ 15 Million for No-Place Trials That Turn “Around the Patient’s Lifestyle”

AppliedVR already has partnerships with the Cleveland Clinic, Boston Children’s Hospital, the University of California, San Francisco and other organizations to test its digital therapy.

The collaboration with Curebase provides AppliedVR with access to remote patient recruitment through tools such as social media, telemedicine functions to communicate with the principal investigator from home, electronic consent, self-reported data transfers, and other capabilities. of decentralized testing, Lemberg said. The pact is initially set for a year, but Lemberg said “we hope it will be a much longer partnership.”

“I think the reason it naturally adapts to digital therapy is that, think about what its products are, they are products that patients use at home, they are often behavioral. So doing all this in a doctor’s office or in an academic hospital just doesn’t fit the real therapy, ”Lemberg said. Curebase has worked with about half a dozen other digital therapy manufacturers, he added. the CEO.

Source link

Leave a Comment

Your email address will not be published. Required fields are marked *